)
Arq (ARQ) investor relations material
Arq Q3 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Record Q3 revenue of $38.2M, up 9% YoY; net income was $2.5M versus a $0.9M loss, and Adjusted EBITDA rose 71% to $8.8M, marking the 10th consecutive positive quarter.
Nine-month revenue was $97.1M and net income was $0.6M, versus $90.9M revenue and a $3.3M net loss in 9M 2025.
Higher PAC volumes and lower production costs following Corbin and GAC pauses supported results; GAC production is not expected in 2026 or 2027.
FY2026 Adjusted EBITDA guidance rose to $19M–$20M; revenue guidance remains $120M–$125M.
Financial highlights
Q3 revenue was $38.2M versus $35.1M; cost of revenue excluding depreciation and amortization fell to $23.0M from $25.0M, with higher volumes driving growth.
Gross margin increased to 39.7% from 28.8%, up ~1,100 bps; operating income was $3.1M versus an operating loss of $1.1M.
Q3 net income was $2.5M, or $0.06 diluted EPS, versus an adjusted net loss of $0.9M, or $(0.02) per share.
Adjusted EBITDA was $8.8M versus $5.2M YoY; SG&A rose to $7.2M from $4.6M on incentive compensation and legal/professional fees.
R&D fell to $0.8M from $2.6M as prior-year GAC ramp-up costs did not recur; 9M operating income was $1.8M versus a $2.4M loss.
Outlook and guidance
FY2026 revenue guidance remains $120M–$125M; Adjusted EBITDA guidance increased to $19M–$20M from $17M–$20M, and CapEx guidance is $8M–$10M.
FY2026 PAC volume guidance is 122M–125M lb, with average selling price of $0.88–$0.91/lb; non-PAC revenue is expected to be 13%–15%.
Management sees a ~$30M 2027 Adjusted EBITDA exit run rate, with growth from PAC, operational efficiencies and sales expansion; the target does not require GAC or associated CapEx.
Meaningful PAC for PFAS orders are viewed as feasible in 2027, with revenue likely back-end loaded; no material 2026 contribution is expected.
Furnace-efficiency and unit-cost initiatives are expected to improve PAC margins; detailed FY2027 guidance is expected early in the new year.
- Q4 profitability rebounded as Red River GAC expansion advanced despite higher costs.ARQ
Q4 2023 - PAC for PFAS trials and operational improvements position the business for strong growth and margin gains.ARQ
Water Tower Research Virtual Insights Conference - PFAS-driven growth, regulatory tailwinds, and product innovation fuel strong financial outlook.ARQ
Investor presentation - Strong Q2 results and regulatory-driven demand position the company for robust growth.ARQ
Conference presentation - Q2 2026 revenue up 5%, margin and EBITDA improved, GAC paused, PAC for PFAS drives outlook.ARQ
Q2 2026 - All proposals, including board elections and incentive plans, passed by majority vote.ARQ
AGM 2026 - Revenue up 7% year-over-year to $29.1M; margins and EBITDA declined, guidance reaffirmed.ARQ
Q1 2026 - Annual meeting covers director elections, compensation, auditor, incentive plan, and tax asset protection.ARQ
Proxy filing - Q3 revenue up 17% to $34.8M, margin gains, and Red River GAC expansion on track.ARQ
Q3 2024
)
)
)
)
)
)
)
)